The Effectiveness of the Unified for Transdiagnostic Treatment on Health Anxiety Comorbid with other Emotional Disorder

The Effectiveness of the Unified Protocol for Transdiagnostic Treatment on Symptoms and Psychological Indicators of University Students with Health Anxiety Comorbid with Other Emotional Disorders: A Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250530065973N1

Enrollment

Registered

2025-06-20

Start date

2025-06-26

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Anxiety. Hypochondriacal disorders

Interventions

Intervention 1: Intervention group: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders consists of up to twelve 45-minute sessions. This treatment targets and modifies emotional

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: The Diagnosis of Health Anxiety Disorder is based a Clinical Interview and the Health Anxiety Questionnaire. Having at least one Emotional Disorder. Providing informed consent to participate in the study. The ability to speak Persian. Participants must be at least 18 years old.

Exclusion criteria

Exclusion criteria: Receiving concurrent psychological treatment. Having other psychiatric disorder. The need for pharmacological intervention. Being absent from more than two therapy sessions.

Design outcomes

Primary

Measure	Time frame
Health Anxiety. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_ up. Method of measurement: Salkovskis et al. Health Anxiety Questionnaire.;Dpression. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_ up. Method of measurement: Beck Depression Inventory(BDI).;Anxiety. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_ up. Method of measurement: Beck Anxiety Inventory(BAI).	—

Measure

Time frame

Health Anxiety. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_ up. Method of measurement: Salkovskis et al. Health Anxiety Questionnaire.;Dpression. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_ up. Method of measurement: Beck Depression Inventory(BDI).;Anxiety. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_ up. Method of measurement: Beck Anxiety Inventory(BAI).

—

Secondary

Measure	Time frame
Distress Tolerance. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Distres?s and Tolerance Scale (DTS) by simons and Gaher.;Experiential Avoidance. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Gamez Eexperiential Questionnare (EAAQ).;Rumination. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Ruminative Responses Scale(RRS) Nolen_ Hoeksema.;Body Awareness. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Body Awareness Questionnaire (BAQ) by shields et al.	—

Measure

Time frame

Distress Tolerance. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Distres?s and Tolerance Scale (DTS) by simons and Gaher.;Experiential Avoidance. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Gamez Eexperiential Questionnare (EAAQ).;Rumination. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Ruminative Responses Scale(RRS) Nolen_ Hoeksema.;Body Awareness. Timepoint: pre_ Treatment, post_ Treatment, and one_ month Follow_. Method of measurement: Body Awareness Questionnaire (BAQ) by shields et al.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Fathi

University of Kurdistan

lham.fathi1@gmail.com+98 87 3872 1255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026